Abstract The Model for End‐stage Liver Disease (MELD) was initially created to predict
survival in patients with complications of portal hypertension undergoing elective placement …

More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

Ascites is a pathologic accumulation of peritoneal fluidcommonly observed in
decompensated cirrhotic states. Its causes are multi-factorial, but principally involve …

Portal vein thrombosis (PVT) is common in cirrhotic patients and presents a challenge at the
time of transplant. Owing to the increased posttransplant morbidity and mortality associated …

Variceal bleeding is one of the major complications of portal hypertension. Gastric variceal
bleeding is less common than esophageal variceal bleeding; however, it is associated with …

OBJECTIVES: Noninvasive markers of liver fibrosis correlate with the stage of liver fibrosis,
but have not been widely applied to predict liver-related mortality. METHODS: We assessed …

Gastric varices in the setting of portal hypertension occur less frequently than esophageal
varices but occur at lower portal pressures and are associated with more massive bleeding …

Background To systematically review literature on use of model for end-stage liver disease
(MELD) score to determine severity and prognosis of liver disease in various clinical …

Background: Inappropriately decreased portosystemic pressure gradient (PSG) during
transjugular intrahepatic portosystemic shunt (TIPS) can cause fatal complications but the …

OBJECTIVES: The objective of this study was to evaluate the incidence of post-balloon-
occluded retrograde transvenous obliteration (BRTO) ascites/hepatic hydrothorax and …